DIPIVEFRIN HYDROCHLORIDE vs LATISSE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. DIPIVEFRIN HYDROCHLORIDE and LATISSE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DIPIVEFRIN HYDROCHLORIDE	LATISSE
Rating	New	72/100
Pharmacy pays	—	$7.87 /mL
Type	RX	RX
Active ingredient	DIPIVEFRIN HYDROCHLORIDE	BIMATOPROST
Manufacturer	Bausch and Lomb	Abbvie
Dosage forms	Drops	Drops
Drug class	—	Prostaglandin Analog
Boxed warning	None	None
Treats	Open-Angle Glaucoma	Open-Angle Glaucoma

dipivefrin hydrochloride latisse

Rating

New

72/100

Pharmacy pays

—

$7.87 /mL

Type

Active ingredient

DIPIVEFRIN HYDROCHLORIDE

BIMATOPROST

Manufacturer

Bausch and Lomb

Abbvie

Dosage forms

Drops

Drug class

—

Prostaglandin Analog

Boxed warning

None

Treats

Open-Angle Glaucoma

Frequently asked questions

What is the difference between Dipivefrin Hydrochloride and Latisse?

Dipivefrin Hydrochloride contains Dipivefrin Hydrochloride, while Latisse contains Bimatoprost — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.